Cola Ingestion for Esophageal Bolus Impaction

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Dec 31, 2026 to Jun 30, 2027
    • Study sites: 4 to 5
    • Eligibility criteria expanded, about 11 words
  2. Study sites: 3 to 4v4
  3. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Jan 1, 2026 to Feb 1, 2026
    • Study completion date: Jun 30, 2026 to Dec 31, 2026
    • Site details revised at 3 of 3 sites
    v3
  4. Start date: Oct 1, 2024 to Nov 1, 2024
    • Study sites: 1 to 3
    • Primary completion date: Oct 1, 2025 to Jan 1, 2026
    • Eligibility criteria expanded, about 6 words
    v2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to observe whether cola ingestion can improve the 24-hour remission rate of acute esophageal impaction in patients with esophageal cancer.
Trial Details
NCT Number NCT06652620
Lead Sponsor Fudan University
Conditions
(from sponsor)		 Esophageal Cancer
Related terms Esophageal Neoplasms
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov